Next-Generation Sequencing Reveals Different Subtypes In Patients With mCRPC, Study Suggests
March 20, 2020
Cancer Therapy Advisor (3/19, Moench) reports researchers “used next-generation sequencing to evaluate both the genome and methylome of circulating plasma DNA from patients with metastatic castration-resistant prostate cancer (mCRPC) revealed different su...